| Identification | Back Directory | [Name]
Pyrano[3,4-d][1,3]thiazin-2-amine, 8a-(2,4-difluorophenyl)-4,4a,5,6,8,8a-hexahydro-4-methyl-6-(3-methyl-5-isoxazolyl)-, (4R,4aR,6R,8aS)- | [CAS]
1621585-17-8 | [Synonyms]
PF9238
PF-9238
PF 9238
PF-06649283 >=98% (HPLC)
Pyrano[3,4-d][1,3]thiazin-2-amine, 8a-(2,4-difluorophenyl)-4,4a,5,6,8,8a-hexahydro-4-methyl-6-(3-methyl-5-isoxazolyl)-, (4R,4aR,6R,8aS)- | [Molecular Formula]
C18H19F2N3O2S | [MDL Number]
MFCD28580118 | [MOL File]
1621585-17-8.mol | [Molecular Weight]
379.42 |
| Chemical Properties | Back Directory | [Boiling point ]
535.7±60.0 °C(Predicted) | [density ]
1.50±0.1 g/cm3(Predicted) | [storage temp. ]
2-8°C | [solubility ]
DMSO: 10mg/mL, clear | [form ]
powder | [pka]
4.24±0.70(Predicted) | [color ]
white to beige |
| Hazard Information | Back Directory | [Description]
PF9238 is a beta-secretase I inhibitor. Treatment with PF9238 results in the accumulation of autofluorescent granules in the retinas. PF9238 has a CatD potency of 12 uM in vivo. | [Uses]
PF-06649283 is a drug with potential intracellular activity. The effects of PF-06649283 may be affected by factors such as cellular metabolism, protein-protein interactions, post-translational modifications, and asymmetric intracellular localization. The potency of PF-06649283 at the cellular level may show different activity compared to the recombinant enzyme, and this difference needs to be considered in the drug discovery process. Increased intracellular potency of PF-06649283 may be critical for the development of this drug as a probe or drug[1]. | [References]
[1] Causes and Significance of Increased Compound Potency in Cellular or Physiological Contexts |
|
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Website: |
http://www.energy-chemical.com |
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
|